EmpiRx Health’s Post

As the health care landscape continues to evolve and greater numbers of novel therapies are approved, it is imperative for organizations to continually assess processes and develop innovative approaches to make these therapies and products available on a medication formulary when clinically indicated. AMCP’s newest health equity action brief, Formulary Management and Benefit Design, charts innovations in formulary management and drug utilization reviews (DUR) to assure equitable access to appropriate medication. https://bit.ly/3WBZYSZ #healthequity #managedcare #pharmacy #formularymanagement

Check out the latest health equity action brief on formulary management-related disparities from a great group of managed care professionals dedicated to helping address health disparities related to medication use and access. #managedcare #healthequity #AMCP

Register now for this live webinar on Parkinson disease! Expert faculty Jessa Koch, PharmD, BCPP, APh, will provide pharmacists with a review of medication-related considerations to equip them in effectively managing OFF episodes and in making clinical recommendations tailored to patient needs while addressing drug-drug interactions and adherence. Learn more: https://bit.ly/3KMEVpI Learner level: Foundational #PTCE #LiveWebinar #CEcredit #FreeCE #pharmacy #pharmacists #ContinuingEducation

Did you know that "off" episodes in Parkinson disease can significantly impact a patient's quality of life, causing unpredictable fluctuations in motor and non-motor symptoms? Join us for a live webinar this Wednesday to gain insights into the latest treatments and techniques for managing "off" episodes, ensuring better care for your patients. Registration information is below:

🌟 Unlocking the Power of Multi-Factorial Precision Prescribing 🌟 In today's rapidly evolving healthcare landscape, precision prescribing is more crucial than ever. Traditional methods of prescribing medications often fail to consider the unique genetic makeup and various health factors of each patient, leading to suboptimal outcomes. Here’s why taking a multi-factorial approach to precision prescribing can revolutionize patient care: Holistic Patient Assessment: By integrating pharmacogenetic (PGx) data with other critical patient information such as liver and kidney function, existing medications, and comorbidities, healthcare providers can make more informed decisions. This comprehensive view helps tailor treatments that are not only effective but also safe for each individual. Enhanced Medication Management: Tools like GenXys' TreatGx and ReviewGx provide real-time, multi-factorial medication optimization. They consider drug-gene interactions along with other patient characteristics, enabling providers to fine-tune medication regimens precisely. Improved Patient Outcomes: By addressing multiple factors influencing drug efficacy and safety, precision prescribing reduces adverse drug reactions and enhances therapeutic efficacy. This leads to better health outcomes and higher patient satisfaction. Cost-Effective Care: Implementing a multi-factorial approach can help healthcare systems avoid the costs associated with adverse drug reactions and ineffective treatments. It also ensures the efficient use of healthcare resources, ultimately leading to cost savings. Staying Ahead with Regulatory Compliance: Navigating the complex landscape of regulatory requirements (CLIA, CAP, FDA) is easier with a multi-factorial approach, ensuring that all aspects of patient care meet the highest standards of safety and efficacy. At GenXys, our precision prescribing solutions are designed to empower healthcare providers with the tools they need to deliver personalized, effective, and safe treatments. Discover how our comprehensive software suite can transform your practice and enhance patient care. 🚀 Ready to revolutionize your prescribing practices? Learn more about our innovative solutions at GenXys #PrecisionPrescribing #Pharmacogenomics #HealthcareInnovation #PatientCare #GenXys #MultiFactorialApproach #PGx

🎓 Just completed a short-term course and hands-on training session on dose calculation for anticancer drugs! 💊 It was an incredible opportunity to refresh my knowledge and dive deep into the precise dosing required for these narrow therapeutic index medications. The insights gained have significantly enhanced my understanding and confidence in this critical aspect of patient care. 💪 Feeling more equipped to make a positive impact on patient outcomes! 🩺 #AnticancerDrugs #PatientCare #DoseCalculation #PharmaceuticalScience #ProfessionalDevelopment #Healthcare #CancerTreatment #LearningJourney #MedicalEducation

Join me on April 10 as I moderate this session with two of MMIT’s best discussing how real world, lab and payer data can help identify access hurdles and overcome them, smoothing patient access to therapies! Be there or be 🔲!

Our clinical teams have once again shown the value of Patient In Home and Community Support Programmes delivering outstanding care to our patients on behalf of their clinicians and our clients. Here are our April highlights. #healthoutcomes #homecare #patientcare #pharma #nhs #clinicaltrials 

On April 10, MMIT’s market access experts will discuss what’s driving pharma companies to focus on patient-level data and analytics. We’ll address the specifics of tracking disease progression, clinical triggers, and more! Register for priority access to the webinar: https://ow.ly/hFyZ50R29qa. #Pharma #PharmaceuticalCompanies #PharmaAnalytics #PatientData #MarketAccess #Webinar

With real-time lab and coverage alerts, your field team can contact high-value physicians before making a prescribing decision. Register for our April 10 webinar to learn all the ways patient-level data can drive utilization: https://ow.ly/5tgn50R6875. #Pharma #PharmaceuticalCompanies #PharmaAnalytics #Physicians #Webinar